Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Br J Ophthalmol. 2020 Nov;104(11):1613-1620. doi: 10.1136/bjophthalmol-2019-315094. Epub 2020 Feb 12.
To report the clinical manifestations, ultrastructure and evaluate the efficacy of therapeutic lamellar keratectomy (TLK) and penetrating keratoplasty (PK) for microsporidial stromal keratitis (MSK).
Fourteen MSK cases between 2009 and 2018 were recruited. Each patient's clinical presentation, light microscopy, histopathology, PCR and electron microscopy (EM) of corneal samples were reviewed.
The patients were 70.0±4.7 years old (average follow-up, 4.5 years). Time from symptoms to presentation was 10.6±13.0 weeks. The corneal manifestations were highly variable. Corneal scrapings revealed Gram stain positivity in 12 cases (85.7%) and modified Ziehl-Neelsen stain positivity in 9 (64.3%). Histopathology revealed spores in all specimens, while sequencing of small subunit rRNA-based PCR products identified in 82% of patients. EM demonstrated various forms of microsporidial sporoplasm in corneal keratocytes. All patients were treated with topical antimicrobial agents or combined with oral antiparasitic medications for >3 weeks. As all patients were refractory to medical therapy, they ultimately underwent surgical intervention (TLK in 7, PK in 6 and 1 received TLK first, followed by PK). Postoperatively, the infection was resolved in 78.6% of the patients. Nevertheless, a high recurrence rate (21.4%) was noted during 3-year follow-up, with only two patients retained a final visual acuity ≥20/100.
MSK usually presents with a non-specific corneal infiltration refractory to antimicrobial therapy. The diagnosis relies on light microscopic examinations on corneal scrapings and histopathological analyses. Surgical intervention is warranted by limiting the infection; however, it was associated with an overall poor outcome.
报告微孢子虫性基质角膜炎(MSK)的临床表现、超微结构,并评估治疗性板层角膜切除术(TLK)和穿透性角膜移植术(PK)的疗效。
回顾性分析 2009 年至 2018 年间收治的 14 例 MSK 患者。分析每位患者的临床表现、光镜、组织病理学、角膜样本的 PCR 和电子显微镜(EM)。
患者年龄为 70.0±4.7 岁(平均随访 4.5 年)。从症状到就诊的时间为 10.6±13.0 周。角膜表现高度可变。12 例(85.7%)角膜刮片革兰染色阳性,9 例(64.3%)改良齐氏染色阳性。所有标本的组织病理学均显示孢子,而基于小亚基 rRNA 的 PCR 产物测序显示 82%的患者存在感染。EM 显示了角膜成纤维细胞中各种形式的微孢子虫孢子体。所有患者均接受了>3 周的局部抗菌药物治疗或联合口服抗寄生虫药物治疗。由于所有患者对药物治疗均无反应,最终均进行了手术干预(7 例行 TLK,6 例行 PK,1 例先 TLK 后 PK)。术后 78.6%的患者感染得到控制。然而,在 3 年的随访中,复发率较高(21.4%),仅 2 例患者最终视力≥20/100。
MSK 通常表现为对抗菌治疗无反应的非特异性角膜浸润。诊断依赖于角膜刮片的光镜检查和组织病理学分析。通过限制感染,手术干预是必要的,但总体预后较差。